Kaulfuss; Stefan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kaulfuss; Stefan.The latest application filed is for "macrocyclic fluorine substituted indole derivatives".
- Kaulfuss; Stefan - Leverkusen DE
- KAULFUSS; Stefan - Berlin DE
| Patent | Date |
|---|---|
| Macrocyclic chlorine substituted indole derivatives Grant 11,447,504 - Thede , et al. September 20, 2 | 2022-09-20 |
| Substituted macrocyclic indole derivatives Grant 11,440,923 - Thede , et al. September 13, 2 | 2022-09-13 |
| Macrocyclic Fluorine Substituted Indole Derivatives App 20220281891 - Ferrara; Steven J. ; et al. | 2022-09-08 |
| Macrocyclic indole derivatives Grant 11,401,278 - Furst , et al. August 2, 2 | 2022-08-02 |
| Macrocyclic fluorine substituted indole derivatives Grant 11,286,263 - Ferrara , et al. March 29, 2 | 2022-03-29 |
| Macrocyclic Indole Derivatives App 20210292341 - Furst; Laura ; et al. | 2021-09-23 |
| Macrocyclic Chlorine Substituted Indole Derivatives App 20210277022 - Thede; Kai ; et al. | 2021-09-09 |
| Substituted Macrocyclic Indole Derivatives App 20210269456 - Thede; Kai ; et al. | 2021-09-02 |
| Aryl Annulated Macrocyclic Indole Derivatives App 20210253598 - Thede; Kai ; et al. | 2021-08-19 |
| Combination of MIDH1 Inhibitors and DNA Hypomethylating Agents (HMA) App 20210113598 - KAULFUSS; Stefan ; et al. | 2021-04-22 |
| Macrocyclic Fluorine Substituted Indole Derivatives App 20210079018 - Ferrara; Steven J. ; et al. | 2021-03-18 |
| Benzimidazol-2-amines as mIDH1 inhibitors Grant 10,442,772 - Rehwinkel , et al. Oc | 2019-10-15 |
| Benzimidazol-2-amines As Midh1 Inhibitors App 20190062285 - REHWINKEL; Hartmut ; et al. | 2019-02-28 |
| 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors Grant 10,137,110 - Rehwinkel , et al. November 27, 2 | 2018-11-27 |
| Benzimidazol-2-amines as mIDH1 inhibitors Grant 9,957,235 - Rehwinkel , et al. May 1, 2 | 2018-05-01 |
| Benzimidazol-2-amines as MIDH1 inhibitors Grant 9,951,027 - Rehwinkel , et al. April 24, 2 | 2018-04-24 |
| 1-cyclohexyl-2-phenylaminobenzimidazoles As Midh1 Inhibitors For The Treatment Of Tumors App 20170319549 - REHWINKEL; Hartmut ; et al. | 2017-11-09 |
| Benzimidazole derivatives as EP4 antagonists Grant 9,708,311 - Peters , et al. July 18, 2 | 2017-07-18 |
| Benzimidazol-2-amines As Midh1 Inhibitors App 20170197922 - REHWINKEL; Hartmut ; et al. | 2017-07-13 |
| Benzimidazol-2-amines As Midh1 Inhibitors App 20170197921 - REHWINKEL; Hartmut ; et al. | 2017-07-13 |
| Novel Benzimidazole Derivatives As Ep4 Antagonists App 20160214977 - PETERS; Olaf ; et al. | 2016-07-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 